article thumbnail

Banyan Group & Paul Hawco on wellness philosophy & evolving preferences in luxury travel 

Spa Executive

In this role, he spearheads the development and implementation of innovative wellness strategies across Banyan Groups diverse portfolio of luxury resorts, spas, and wellbeing experiences. PH: As Director of Integrated Wellbeing, I lead the strategic vision and execution of the Groups wellbeing portfolio.

article thumbnail

U.S. FDA Clears Avita Medical’s Cohealyx for Healing Full-thickness Wounds

The Dermatology Digest

Branded by AVITA Medical and co-developed with Regenity Biosciences, Cohealyx may reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. Cohealyx comprises a bovine collagen-based design that is engineered to facilitate cellular migration and blood vessel formation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. FDA Approves Celltrion’s STELARA Biosimilar

The Dermatology Digest

. “The approval of STEQEYMA reflects Celltrion’s continued investment in providing treatment options to patients diagnosed with ulcerative colitis, Crohn’s disease, psoriasis, and psoriatic arthritis,” says Thomas Nusbickel, Chief Commercial Officer at Celltrion USA, in a news release. immunology market.”

article thumbnail

Galderma & PatientFi Announce a Monthly Membership Program for Custom Galderma Treatment Plans

MedEsthetics

The monthly membership pays for custom treatment plans with Galderma’s portfolio of innovative aesthetic products, all while earning patient loyalty points through Aspire Galderma Rewards.

article thumbnail

Galderma & PatientFi Announce a Monthly Membership Program for Custom Galderma Treatment Pans

MedEsthetics

The monthly membership pays for custom treatment plans with Galderma’s portfolio of innovative aesthetic products, all while earning patient loyalty points through Aspire Galderma Rewards.

article thumbnail

JNJ Continues to Grow AD Pipeline With New Licensing Agreement

The Dermatology Digest

By modulating STAT6, KP-723 complements the Companys portfolio of molecules targeting pathways relevant to AD. Nearly three-quarters of people with atopic dermatitis are not achieving remission with currently available treatments,adds Candice Long, Worldwide Vice President, Immunology, Johnson & Johnson.

article thumbnail

GlossGenius vs. Vagaro: Best Booking Systems for Estheticians?

Maxine Drake

Branding & Business Website Customizable website with options to showcase team members, services, and portfolios. Allowing clients to pick facials or advanced treatments without a consultation can backfire. This ensures you create the right treatment plan instead of correcting mistakes later. But for skincare?